Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -116.42% is 13% above its 5-year average of -134.00%, near the high end of its 5-year range (-502.60%–13.29%).
As of the fiscal period ended Tuesday, June 30, 2026. 39.09% above its 12-month average of -191.14%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -116.42%.
RETURN ON EQUITY (ROE)
-116.42%
RETURN ON EQUITY (ROE) AVG TTM
-191.14%
RETURN ON EQUITY (ROE) AVG 3Y
-151.96%
RETURN ON EQUITY (ROE) AVG 5Y
-134.00%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+39.09%
CURRENT VS 3Y AVG
+23.38%
CURRENT VS 5Y AVG
+13.11%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-37.66%
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
-209.15%
vs the sector median at left
Precision BioSciences, Inc.
Market Cap
$174.17M
Return on Equity (ROE)
-116.42%
TTM Avg
-191.14%
3Y Avg
-151.96%
5Y Avg
-134.00%
Market Cap
$173.04M
Return on Equity (ROE)
-215.26%
TTM Avg
-150.35%
3Y Avg
8.65%
5Y Avg
-35.35%
Market Cap
$172.99M
Return on Equity (ROE)
-44.23%
TTM Avg
-36.61%
3Y Avg
-30.86%
5Y Avg
-42.66%
Market Cap
$176.96M
Return on Equity (ROE)
-7104.24%
TTM Avg
-166.54%
3Y Avg
-137.65%
5Y Avg
-112.46%
Market Cap
$179.70M
Return on Equity (ROE)
-21.57%
TTM Avg
-470.91%
3Y Avg
-299.18%
5Y Avg
-180.76%
Market Cap
$184.12M
Return on Equity (ROE)
-19.01%
TTM Avg
-54.50%
3Y Avg
-75.60%
5Y Avg
-59.28%
Market Cap
$162.82M
Return on Equity (ROE)
-59.40%
TTM Avg
-255.06%
3Y Avg
-160.44%
5Y Avg
-112.56%
Market Cap
$160.82M
Return on Equity (ROE)
-14.07%
TTM Avg
-16.23%
3Y Avg
-27.66%
5Y Avg
-19.01%
Market Cap
$192.97M
Return on Equity (ROE)
-136.83%
TTM Avg
-43.45%
3Y Avg
-452.04%
5Y Avg
-306.86%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Precision BioSciences, Inc. (DTIL) | $174.17M | -116.42% | -191.14% | -151.96% | -134.00% |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | -215.26% | -150.35% | 8.65% | -35.35% |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | -44.23% | -36.61% | -30.86% | -42.66% |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | -7104.24% | -166.54% | -137.65% | -112.46% |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | -21.57% | -470.91% | -299.18% | -180.76% |
| Journey Medical Corporation (DERM)vs › | $184.12M | -19.01% | -54.50% | -75.60% | -59.28% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | -59.40% | -255.06% | -160.44% | -112.56% |
| Inogen, Inc. (INGN)vs › | $160.82M | -14.07% | -16.23% | -27.66% | -19.01% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $192.97M | -136.83% | -43.45% | -452.04% | -306.86% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | -183.44% | -114.28% | -67.72% | -46.03% |
ROE
-116.4%
ROA
-41.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -116.42% |
| 2026-03-31 | -57.29% |
| 2025-12-31 | -49.57% |
| 2025-09-30 | -502.60% |
| 2025-06-30 | -229.80% |
| 2025-03-31 | -44.56% |
| 2024-12-31 | 12.71% |
| 2024-09-30 | 13.29% |
| 2024-06-30 | 11.41% |
| 2024-03-31 | -97.27% |
| 2023-12-31 | -370.27% |
| 2023-09-30 | -282.27% |
| 2023-06-30 | -262.79% |
| 2023-03-31 | -270.13% |
| 2022-12-31 | -184.73% |
| 2022-09-30 | -124.96% |
| 2022-06-30 | -90.05% |
| 2022-03-31 | -57.54% |
| 2021-12-31 | -33.57% |
| 2021-09-30 | -31.31% |
| 2021-06-30 | -46.25% |
| 2021-03-31 | -171.46% |
| 2020-12-31 | -245.37% |
| 2020-09-30 | -166.82% |
| 2020-06-30 | -118.22% |
| 2020-03-31 | -76.44% |
| 2019-12-31 | -67.15% |
| 2019-09-30 | -56.10% |
| 2019-06-30 | -43.92% |
| 2019-03-31 | -635.35% |
| 2018-12-31 | -115.21% |
